Publisher: Icon Group International, Inc.
Category: Prescription Drugs

Prescription Drugs market research reports by Icon Group International, Inc.

(297 reports matching your criteria)
    • The 2025-2030 World Outlook for Medication Dispensing and Packaging Systems

      The 2025-2030 World Outlook for Medication Dispensing and Packaging Systems This study covers the world outlook for medication dispensing and packaging systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Dyspepsia Medications

      The 2025-2030 World Outlook for Dyspepsia Medications This study covers the world outlook for dyspepsia medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Prescription Sleep-Aid Insomnia Drugs

      The 2025-2030 World Outlook for Prescription Sleep-Aid Insomnia Drugs This study covers the world outlook for prescription sleep-aid insomnia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for HIV-AIDS Drugs

      The 2025-2030 World Outlook for HIV-AIDS Drugs This study covers the world outlook for HIV-AIDS drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More

    • The 2025-2030 World Outlook for Subcutaneous Immunoglobulins

      The 2025-2030 World Outlook for Subcutaneous Immunoglobulins This study covers the world outlook for subcutaneous immunoglobulins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Subcutaneous Immunoglobin

      The 2025-2030 World Outlook for Subcutaneous Immunoglobin This study covers the world outlook for subcutaneous immunoglobin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Dermatitis Drugs

      The 2025-2030 World Outlook for Dermatitis Drugs This study covers the world outlook for dermatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Pharma Contract Sales

      The 2025-2030 World Outlook for Pharma Contract Sales This study covers the world outlook for pharma contract sales across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics

      The 2025-2030 World Outlook for Cervical Cancer Drugs and Diagnostics This study covers the world outlook for cervical cancer drugs and diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Helicobacter Pylori Diagnostics

      The 2025-2030 World Outlook for Helicobacter Pylori Diagnostics This study covers the world outlook for helicobacter pylori diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Veterinary Therapeutics

      The 2025-2030 World Outlook for Veterinary Therapeutics This study covers the world outlook for veterinary therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Antidiabetics

      The 2025-2030 World Outlook for Antidiabetics This study covers the world outlook for antidiabetics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More

    • The 2025-2030 World Outlook for Antiemetic Drugs

      The 2025-2030 World Outlook for Antiemetic Drugs This study covers the world outlook for antiemetic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Dysphagia Management

      The 2025-2030 World Outlook for Dysphagia Management This study covers the world outlook for dysphagia management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Antibacterial Hospital Acquired Pneumonia Drugs

      The 2025-2030 World Outlook for Antibacterial Hospital Acquired Pneumonia Drugs This study covers the world outlook for antibacterial hospital acquired pneumonia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More

    • The 2025-2030 World Outlook for Sirolimus

      The 2025-2030 World Outlook for Sirolimus This study covers the world outlook for sirolimus across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More

    • The 2025-2030 World Outlook for Wholesale and Distribution of Branded Drug Pharmaceuticals

      The 2025-2030 World Outlook for Wholesale and Distribution of Branded Drug Pharmaceuticals This study covers the world outlook for wholesale and distribution of branded drug pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potentia ... Read More

    • The 2025-2030 World Outlook for Diabetic Gastroparesis Drugs

      The 2025-2030 World Outlook for Diabetic Gastroparesis Drugs This study covers the world outlook for diabetic gastroparesis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Chronic Obstructive Pulmonary Disease Treatments

      The 2025-2030 World Outlook for Chronic Obstructive Pulmonary Disease Treatments This study covers the world outlook for chronic obstructive pulmonary disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More

    • The 2025-2030 World Outlook for Hormone-Based Therapy Infertility Drugs

      The 2025-2030 World Outlook for Hormone-Based Therapy Infertility Drugs This study covers the world outlook for hormone-based therapy infertility drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Human Chorionic Gonadotropin (hCG)

      The 2025-2030 World Outlook for Human Chorionic Gonadotropin (hCG) This study covers the world outlook for human chorionic gonadotropin (hCG) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Anti-Inflammatory Lupus Drugs

      The 2025-2030 World Outlook for Anti-Inflammatory Lupus Drugs This study covers the world outlook for anti-inflammatory Lupus drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Medication for Companion Animals

      The 2025-2030 World Outlook for Medication for Companion Animals This study covers the world outlook for medication for companion animals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Pirfenidone

      The 2025-2030 World Outlook for Pirfenidone This study covers the world outlook for pirfenidone across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More

    • The 2025-2030 World Outlook for Hypothyroidism Treatments

      The 2025-2030 World Outlook for Hypothyroidism Treatments This study covers the world outlook for hypothyroidism treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

1 2 3 4 5 6 7 8 9 10

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings